Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 05 Oct 2026 for BridgeBio Oncology Therapeutics, Inc., €1,192.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Idan Elmelech: trading record in brief
Idan Elmelech discloses dealings in BridgeBio Oncology Therapeutics, Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 1 July 2026 and the latest from 1 October 2026.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 5 October 2026, reports a share grant of €1,192 in BridgeBio Oncology Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Idan Elmelech
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
343 shares@ US$3.940.0004% mcap33.6% of flowCommon StockSEC:0001193125-26-414131:0
343 shares@ US$7.800.0008% mcap100.0% of flowCommon StockSEC:0001193125-26-296503:0
2 of 2 declarations
